Noto, Takanori
Seto, Hiroki
Fukuhara, Junji
Murabayashi, Masao
Yachie, Akihiro
Ayusawa, Mamoru
Morioka, Ichiro http://orcid.org/0000-0002-5685-2670
Article History
Received: 4 September 2018
Accepted: 4 December 2018
First Online: 12 December 2018
Ethics approval and consent to participate
: Ethics approval was obtained from the ethics committee in Numazu City Hospital (approval number 2018–0008). The patient’s guardian provided the written informed consent to participate.
: We obtained the written consent for publication from the guardian of the patient.
: All authors have no conflicts of interest to declare for this work. Outside the submitted work, I.M. has received grants from Japan Blood Product Organization, Daiichi Sankyo Co., Ltd., MSD Co., Ltd., AbbVie LLC, Taisho Toyama Pharmaceutical Co., Ltd., and Air Water Inc.; lecture fees from MSD Co., Ltd., Pfizer Japan, Inc., Novo Nordisk Pharma Ltd., Shionogi Co., Ltd., AbbVie LLC, Japan Vaccine Co., Ltd., Asahikasei Medical Co., Ltd., and Atom Medical Corp.; manuscript fees from Atom Medical Corp., Sanofi K.K., Asahikasei Medical Co., Ltd., and Japan Blood Product Organization,; and honoraria from Sanofi K.K.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.